ObsEva SA

Industry · 10 registered clinical trials.

Status	Trial	Phase	Started
Completed	Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function Renal Impairment, Healthy Participants	Phase 1	2019-05-15
Completed	Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function Hepatic Impairment, Healthy Participants	Phase 1	2019-05-15
Completed	Study of Nolasiban to Increase Pregnancy Rates in Women Undergoing IVF Infertility	Phase 3	2019-01-10
Unknown	PoC Study of OBE022 in Threatened Preterm Labour Preterm Labor	Phase 2	2018-01-10
Completed	Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids Uterine Fibroids, Heavy Menstrual Bleeding	Phase 3	2017-05-23
Completed	Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids Uterine Fibroids, Heavy Menstrual Bleeding	Phase 3	2017-04-20
Completed	Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI Infertility	Phase 3	2017-03-06
Completed	A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis Endometriosis	Phase 2	2016-07-01
Terminated	A Phase 2 Study of OBE001 Versus Placebo in the Delay of Preterm Birth Preterm Labor	Phase 2	2015-03-01
Completed	OBE001 Phase 2 Dose-finding Study Versus Placebo in Women Undergoing Embryo Transfer in the Context of IVF-ICS Infertility	Phase 2	2014-11-01